Stocks / NASDAQ / Nanobiotix S.A.

Nanobiotix S.A.

Our Opinion

Nanobiotix S.A. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“Mice were injected in both flanks with 344SQ_R cells (murine lung carcinoma, resistant to anti-PD1). NBTXR3 was administered by intratumoral injection (25% of baseline tumor volume). Anti-PD1 (200μg) was delivered by i.p. injection at Day -2, 1, 4, 7, 12, 14, and 21 (8 mice per group). Tumor growth was followed, and animals sacrificed when tumors reached 800mm3. Read the full document

Company Description

Nanobiotix SA is a France-based oncology-focused nanomedicine company. The Company is engaged in developing nanoparticle technology. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. The Company develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell.

Company Website: